… We detail the use of the quality-adjusted life-year (QALY) in resource allocation decisions, …
analyses include estimating the cost-per-QALY (quality-adjusted life-year) of interventions. …

… in multiple sclerosis, but it is not known whether patient reported outcomes are also
affected… This study investigates the relationship between treatment timing and patient-reported …

… 855 MS patients from the Swiss Multiple Sclerosis Registry found slightly higher prevalences
… the importance of including standardized patient reported outcome measures, and not only …

… , demographics, clinical data, and patient-reported outcomes are captured during outpatient
… estimation of quality-adjusted life-years (QALYs), which are a policy-relevant measure for …

… for relapsing-remitting multiple sclerosis (RRMS) observed in … Markov model was used
to measure the effect of DMDs on … , disability progression, and quality-adjusted life-years (QALYs). …

… use of the quality-adjusted life year (QALY) to measure health … For example, drugs that treat
multiple sclerosis reduce the rate … , whether it is measured through patient-reported or clinical …

… mobility, including cerebral palsy, multiple sclerosis, and arthritis. Eleven dimensions of …
quality-adjusted life year (QALY) [Citation4], which is derived from preference-based measures …

… Cost-effectiveness is commonly expressed as the cost per quality-adjusted life-year (QALY)
of the intervention. QALYs assess both the length and quality of life as a single measure, …

… Moreover, high-quality patient-reported outcome data with … a patient-reported outcome
qualityadjusted life-year—ie, the … optimal multiple sclerosis care is a shared ethical imperative. …

… in terms of cost per quality-adjusted life year (QALY) gained. … Therefore, the purpose of this
study was to develop a scoring … for the Patient-Reported Outcomes Measurement Information …